abstract |
The invention relates to new derivatives of myricetin and application of compounds to medicine preparation. The new derivatives of the myricetin have the structural formula which is shown in the specifications, wherein R1 is H or glucuronic acid and sodium salt thereof or arginine salt, R2 is H or glucuronic acid and sodium salt thereof or arginine salt, R3 is H or SO3Na, and R4 is OH or SO3Na. The invention relates to the application of the new derivatives of myricetin to preparation of medicines for treating and preventing cardiovascular and cerebrovascular diseases. |